Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy Participants
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-12-24
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability, and pharmacokinetics (PK) of ART5803 following IVIG administration in healthy participants to investigate the potential interactions between ART5803 and IVIG